logo

For the Inventor, By the Inventor

Asaka, Japan

Shigeru Takanashi

This inventor holds 5 USPTO granted patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1982-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Takanashi. Retrieved from https://idiyas.com/inventor/shigeru-takanashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Asaka, JP (1982 - 1983)
  • Saitama, JP (1985)

Company Filing History:

goldMedal5 out of 987 
 
Chugai Seiyaku Kabushiki Kaisha
 patents

Years Active: 1982-1985

Loading Chart...
5 patents (USPTO):Explore Patents
1. 4507309 - Pharmaceutical composition for treating transplanted tumor cells (1985-03-26),
2. 4415573 - Novel uracil derivatives, process for preparing the same and a (1983-11-15),
3. 4379150 - Dibenz[b,f][1,4]oxazepine derivatives, process for preparing the same, (1983-04-05),
4. 4366161 - Nicotinamide derivative, process for preparing the same and (1982-12-28),
5. 4361572 - Tetrahydronicotinamide derivative, pharmaceutical compositions and use (1982-11-30),

Title: Shigeru Takanashi: Innovator in Pharmaceutical Composition

Introduction

Shigeru Takanashi is a notable inventor based in Asaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating transplanted tumor cells. With a total of 5 patents to his name, Takanashi's work is recognized for its potential impact on cancer treatment.

Latest Patents

Among his latest patents, Takanashi has developed a pharmaceutical composition aimed at treating transplanted tumor cells. This composition features an effective ingredient that is an anthranyl derivative, which is detailed in the patent documentation. Additionally, he has disclosed novel uracil derivatives, which possess good antitumor activity and are useful as antitumor preparations. These derivatives and their pharmaceutically acceptable salts are also part of his innovative contributions.

Career Highlights

Takanashi is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on groundbreaking research and development in cancer treatment.

Collaborations

Throughout his career, Takanashi has collaborated with esteemed colleagues, including Yasushi Murakami and Tamotsu Yamazaki. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Shigeru Takanashi's contributions to pharmaceutical compositions demonstrate his commitment to advancing cancer treatment. His innovative patents and collaborations highlight his role as a key figure in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…